Pattern of Salivary Gland Tumours among Patients Attending Otorhinolaryngology and Maxillofacial Services at Tertiary Hospital in Tanzania, A Cross-Sectional Study

  • Enica Richard Massawe Muhimbili University of Health and Allied Sciences
  • John Masago Muhimbili National Hospital
  • Edwin Liyombo Muhimbili National Hospital
Keywords: Pattern, Salivary Gland, Tumours, Tertiary Hospital
Share Article:

Abstract

The proportion of neoplasms of the salivary gland in the study population accounted for 10% of all head & neck and 3% of all neoplasms in the body. There is a scarcity of information regarding salivary gland tumours in Tanzania; therefore, this study addresses important issues in prevalence, histological, demographic characteristics, co-morbidities and treatment of salivary gland tumours. This study aimed to determine the pattern of salivary gland tumours among patients attending Otorhinolaryngology and Maxillofacial services at a tertiary hospital. This was a cross-sectional study done on patients diagnosed with salivary gland tumours. A total of 276 patients were recruited. Pre-tested coded questionnaires were used to collect data which were later analysed using SPSS statistical computer software version 20.0. Of the studied 276 participants, 156 (56.5%) were males, and 120 (43.5%) were females. Their age group ranged between 0 to 90 years with a mean age of 49.47 years, SD ±15.7. Most of them, 69 (28.6 %) aged above 60 years, and 31 (26.1 %) were in the age group of 40-49 and 60+ years. Mostly affected were males, 64 (55.1%) and 52 (44.8%) were females, P=0.76. The most commonly affected site was the parotid gland (75%), and the least affected sites were submandibular and sublingual (7.5%). Among 116 patients, malignant and benign types accounted for 76 (66%) and 40 (34%), respectively. Both benign and malignant salivary gland tumours (SGT) had male preponderance. Pleomorphic adenoma was high in males (28.1%) compared to females (25.0%); mucoepidermoid carcinoma was commonly found, accounting for 23.4% in males and 28.9% in females. More males were commonly affected, particularly the 40-49 age group, although the differences were statistically insignificant (p-value= 0.07).             In conclusion, the majority of salivary gland tumours were malignant type and mucoepidermoid carcinoma being the most common histological type, while pleomorphic adenoma was the most frequently encountered benign type, and both had male preponderance, mostly seen at the age of 40 years and above. The majority of patients with malignant tumours presented late to the hospital; therefore, there is a need for advocacy for early health-seeking behaviour to the community and early detection of the disease by health personnel in the primary health centres.

Downloads

Download data is not yet available.

References

Ten Cate’s Oral Histology, Nanci, Elsevier, 2013, page 275-276

Rosen EJ. Salivary GlandNeoplasms.http://emedicine.medscape.com/article/852373. 2002;

Illustrated Anatomy of the Head and Neck, Fehrenbach and Herring, Elsevier, 2012, p. 157

Xiao CC, Zhan KY, White-Gilbertson SJ, Day TA. Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients. Otolaryngol Head Neck Surg 2016; 154:121.

de Oliveira FA, Duarte EC, Taveira CT, Maximo AA, de Aquino EC, Alencar RC, et al. Salivary gland tumour: a review of 599 cases in a Brazilian population. Head and neck pathology. 2009; 3:271-5.

Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. International journal of oral and maxillofacial surgery. 2010; 39:235-42.

Lukšić I, Virag M, Manojlović S, Macan D. Salivary gland tumours: 25 years of experience from a single institution in Croatia. Journal of cranio-maxillo-facial surgery. 2012;40: e75-81

Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 2015; 146:51-8.

Eveson JW. Salivary tumours. Periodontol 2000. 2011;57:150-9

Otoh EC, Johnson NW, Olasoji H,Danfillo IS, Adeleke OA. Salivary gland neoplasms in Maiduguri, north-eastern Nigeria. Oral Dis. 2005;11:386-91

Ito FA, Ito K, Vargas PA, de Almeida OP, Lopes MA. Salivary gland tumours in a Brazilian population: a retrospective study of 496 cases. International journal of oral and maxillofacial surgery. 2005; 34:533-6.

Shishegar M, Ashraf MJ, Azarpira N, Khademi B, Hashemi B, Ashrafi A. Salivary gland tumours in maxillofacial region: a retrospective study of 130 cases in a southern Iranian population. Pathology research international. 2011;2011:934350

Barnes L, Eveson JW, Reichert P, et al. World health classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2017.

Ellis GL, Auclair PL. Atlas of tumour pathology. Tumours of the salivary glands. Washington DC: AFIP; 1995.

To VSH, Chan JYW, Tsang RKY, Wei WI. Review of Salivary Gland Neoplasms. ISRN Otolaryngol. 2012;2012:1–6.

Y. Y. P. Lee, K. T. Wong, A. D. King, and A. T. Ahuja, “Imaging of salivary gland tumours,” European Journal of Radiology, vol. 66, no. 3, pp. 419–436, 2008.

S. R. Orell, “Diagnostic difficulties in the interpretation of fine needle aspirates of salivary gland lesions: the problem revisited,” Cytopathology, vol. 6, no. 5, pp. 285–300, 1995.

Stenner M, Klussmann JP. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. Eur Arch Otorhinolaryngol. 2009 Mar. 266(3):333-41

K. H. Lam, W. I. Wei, H. C. Ho, and C. M. Ho, “Whole organ sectioning of mixed parotid tumours, “American Journal of Surgery, vol. 160, no. 4, pp. 377–381

Elledge R. Current concepts in research related to oncogenes implicated in salivary gland tumourigenesis: a review of the literature. Oral Dis. 2009 May. 15(4):249-54

American Joint Committee on Cancer Staging Manual, 7th ed, Edge SB, Byrd DR, Compton CC, et al. (Eds), Springer, New York 2010.

Spuntarelli G, Santecchia L, Urbani U, Zama M. Minor salivary gland neoplasm in children. J Craniofac Surg. 2013 Mar. 24(2):664-7.

Ritwik P, Brannon RB. A clinical analysis of nine new pediatric and adolescent cases of benign minor salivary gland neoplasms and a review of the literature. J Med Case Rep. 2012 Sep 11. 6(1):287.

Bello IO, Salo T, Dayan D, Tervahauta E, Almangoush A, Schnaiderman-Shapiro A, Barshack I, Leivo I, Vered M. Epithelial salivary gland tumours in two distant geographical locations, Finland (Helsinki and Oulu) and Israel (Tel Aviv): a 10-year retrospective comparative study of 2,218 cases. Head Neck Pathol. 2012 Jun;6(2):224-31. doi: 10.1007/s12105-011-0316-5. Epub 2012 Jan 7. PMID: 22228070; PMCID: PMC3370031.

Pathology O. Clinicopathological analysis of salivary gland tumors over a 15-year period. 2016;30:1–7.

Tumours of the Salivary Glands. In: Pathology and Genetics of Head and Neck Tumours, Barnes L, Eveson JW, Reichart P, Sidransky D. (Eds), World Health Organization, Lyon 2005. p.209.

Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8:177.

M. Guzzo, L. D. Locati, F. J. Prott, G. Gatta, M. McGurk, and L. Licitra, “Major and minor salivary gland tumours,” Critical Reviews in Oncology/Hematology, vol. 74, no. 2, pp. 134–148, 2010.

Fomete B, Adebayo ET, Ononiwu CN. Management of salivary gland tumors in a Nigerian tertiary institution. Ann Afr Med. 2015;14(3):148–54.

Araya J, Martinez R, Niklander S, Marshall M, Esguep A. Incidence and prevalence of salivary gland tumours in Valparaiso, Chile. 2015.

Kızıl Y, Aydil U, Ekinci O, Dilci A, Köybaşıoğlu A, Düzlü M, et al. Salivary gland tumors in Turkey: demographic features and histopathological distribution of 510 patients. Indian J Otolaryngol Head Neck Surg

Silas O A, Echejoh G O, Menasseh A N, Mandong B M, Otoh E C. Descriptive pattern of salivary gland tumours in Jos University Teaching Hospital: A 10-year retrospective study. Ann Afr Med 2009;8:199-202

Masanja MI, Kalyanyama BM, Simon EN. Salivary gland tumours in Tanzania. West India Med J 2001; 50:62-5.

Hill AG. Major salivary gland tumours in a rural Kenyan hospital. Laryngoscope 1997; 107:127-80.

Onyango, J.E., Awange, D.O. and Wakiaga, J.M. Oral tumours and tumour-like conditions in Kenya. I Histological distribution. East. Afr. Med. J. 1995; 72:560-563.

Shafiquil IM, Md Azharul Islam, Md Abdus Sattar, AFM Ekramuddula HI Al, Hadi. Malignant Salivary Gland Neoplasm - clinicopathological Study Mohammed Shafiqul Islam, Md Azharul Islam, Md Abdus Sattar, AFM Ekramuddula, Hossain Imam Al Hadi. Bangladesh J Otorhinolaryngol 2008; 14(1) 1-5. 14(1):1–5

Torabinia N, Khalesi S. Clinicopathological study of 229 cases of salivary gland tumours in Isfahan population. Dent Res J (Isfahan). 2014 Sep;11(5):559-63. PMID: 25426146; PMCID: PMC4241608.

Kayembe MKA, Kalengayi MMR. Salivary gland tumours in Congo (Zaire). OdontostomatolTrop[Internet].2002;25(99):1922.Availablefrom:http://www.ncbi.nlm.nih.gov/pubmed/12430

Published
16 July, 2023
How to Cite
Massawe, E., Masago, J., & Liyombo, E. (2023). Pattern of Salivary Gland Tumours among Patients Attending Otorhinolaryngology and Maxillofacial Services at Tertiary Hospital in Tanzania, A Cross-Sectional Study. East African Journal of Health and Science, 6(1), 251-262. https://doi.org/10.37284/eajhs.6.1.1315